Clinical trial
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for…
NCT00003138 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003138 |
|---|---|
| Title | Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes |
| Official title | Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Myelodysplastic Syndromes |
| Intervention type | Biological, Procedure |
| Interventions | Erythropoietin, Filgrastim, Transfusion |
| Enrollment | 118 |
| Start date | Mar 4, 1998 |
| Primary completion | Aug 1, 2008 |
| Completion | May 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 29, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: